Lista de obras -

"Trying to be a good parent" as defined by interviews with parents who made phase I, terminal care, and resuscitation decisions for their children

artículo científico publicado en 2009

A phase 1 trial of everolimus and bevacizumab in children with recurrent solid tumors

scientific article published on 22 January 2020

A phase 1/pilot study of radiofrequency ablation for the treatment of recurrent pediatric solid tumors

artículo científico publicado en 2009

A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastoma ⬇️

artículo científico publicado el 28 de julio de 2011

Avoiding misdiagnosing neuroblastoma as Wilms tumor

artículo científico publicado en 2008

Bereaved parents' perceptions about when their child's cancer-related death would occur

artículo científico publicado en 2009

Clinical and diagnostic imaging findings predict anesthetic complications in children presenting with malignant mediastinal masses

artículo científico publicado en 2007

Clinically ascertained health outcomes, quality of life, and social attainment among adult survivors of neuroblastoma: A report from the St. Jude Lifetime Cohort

artículo científico publicado en 2020

Colorectal carcinoma in childhood and adolescence: a clinicopathologic review

artículo científico publicado en 2007

Comparison of pain outcomes between two anti-GD2 antibodies in patients with neuroblastoma.

artículo científico publicado en 2014

Contrast-enhanced sonography of malignant pediatric abdominal and pelvic solid tumors: preliminary safety and feasibility data ⬇️

artículo científico publicado el 17 de enero de 2012

Current Management of Neonatal Liver Tumors

artículo científico

Current and Future Management Strategies for Relapsed or Progressive Hepatoblastoma

artículo científico publicado el 1 de agosto de 2012

Decision making by parents of children with incurable cancer who opt for enrollment on a phase I trial compared with choosing a do not resuscitate/terminal care option

artículo científico publicado en 2010

Differential diagnosis and work-up of elevations of alkaline phosphatase following therapy for pediatric cancer

artículo científico publicado en 2008

Disease control intervals in high-risk neuroblastoma

artículo científico publicado en 2008

Dose escalation of intravenous irinotecan using oral cefpodoxime: A phase I study in pediatric patients with refractory solid tumors ⬇️

artículo científico publicado el 20 de abril de 2011

Epidemiology and management options for colorectal cancer in children

scientific article published on January 2008

Epidermal growth factor receptor polymorphisms and risk for toxicity in paediatric patients treated with gefitinib

artículo científico publicado en 2010

Evaluation of gefitinib for treatment of refractory solid tumors and central nervous system malignancies in pediatric patients

artículo científico publicado en 2006

Factors that distinguish symptoms of most concern to parents from other symptoms of dying children

artículo científico publicado en 2010

Familial adenomatous polyposis in two brothers with hepatoblastoma: implications for diagnosis and screening

artículo científico publicado en 2006

Feasibility of Pegylated Interferon in Children and Young Adults With Resected High-Risk Melanoma.

artículo científico publicado en 2016

Imaging analysis of hepatoblastoma resectability across neoadjuvant chemotherapy.

scientific article published on June 2013

Management of Colorectal Carcinoma in Children and Young Adults ⬇️

artículo científico publicado el 1 de mayo de 2012

Multimodality Treatment of Pediatric Esthesioneuroblastoma.

artículo científico publicado en 2015

Parent-clinician communication intervention during end-of-life decision making for children with incurable cancer.

artículo científico publicado en 2012

Phase 1 study of an oxaliplatin and etoposide regimen in pediatric patients with recurrent solid tumors

artículo científico publicado en 2009

Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors: a children's oncology group study

artículo científico publicado en 2009

Phase I and clinical pharmacology study of bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory/recurrent solid tumors.

artículo científico publicado en 2012

Phase I and pharmacokinetic study of topotecan administered orally once daily for 5 days for 2 consecutive weeks to pediatric patients with refractory solid tumors

artículo científico publicado en 2004

Phase I clinical trial of ifosfamide, oxaliplatin, and etoposide (IOE) in pediatric patients with refractory solid tumors

artículo científico publicado en 2015

Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma

artículo científico publicado en 2014

Pilot study to evaluate MYCN expression as a neuroblastoma cell marker to detect minimal residual disease by RT-PCR.

artículo científico publicado en 2006

Radiation therapy as part of local control of metastatic neuroblastoma: the St Jude Children's Research Hospital experience.

artículo científico publicado en 2010

Rapamycin increases neuroblastoma xenograft and host stromal derived osteoprotegerin inhibiting osteolytic bone disease in a bone metastasis model ⬇️

artículo científico publicado el 1 de enero de 2013

Rare Tumors in Children: Progress Through Collaboration

artículo científico publicado en 2015

Reducing irinotecan-associated diarrhea in children

artículo científico publicado en 2008

Safety of ultrasound contrast agents in the pediatric oncologic population: a single-institution experience

artículo científico publicado en 2014

Serum ALT elevations in survivors of childhood cancer. A report from the St. Jude Lifetime Cohort Study

Subsequent malignant neoplasms in pediatric patients initially diagnosed with neuroblastoma

artículo científico publicado en 2015

The role of chest computed tomography (CT) as a surveillance tool in children with high-risk neuroblastoma.

artículo científico publicado en 2015

Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007

artículo científico publicado en 2012

Typhlitis in childhood cancer

artículo científico publicado en 2005

Tyrosine kinase inhibitor enhances the bioavailability of oral irinotecan in pediatric patients with refractory solid tumors

artículo científico publicado en 2009

Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee.

artículo científico publicado en 2017

Lista de obras de

"Trying to be a good parent" as defined by interviews with parents who made phase I, terminal care, and resuscitation decisions for their children

A phase 1 trial of everolimus and bevacizumab in children with recurrent solid tumors

A phase 1/pilot study of radiofrequency ablation for the treatment of recurrent pediatric solid tumors

A single-arm pilot phase II study of gefitinib and irinotecan in children with newly diagnosed high-risk neuroblastoma ⬇️

Avoiding misdiagnosing neuroblastoma as Wilms tumor

Bereaved parents' perceptions about when their child's cancer-related death would occur

Clinical and diagnostic imaging findings predict anesthetic complications in children presenting with malignant mediastinal masses

Clinically ascertained health outcomes, quality of life, and social attainment among adult survivors of neuroblastoma: A report from the St. Jude Lifetime Cohort

Colorectal carcinoma in childhood and adolescence: a clinicopathologic review

Comparison of pain outcomes between two anti-GD2 antibodies in patients with neuroblastoma.

Contrast-enhanced sonography of malignant pediatric abdominal and pelvic solid tumors: preliminary safety and feasibility data ⬇️

Current Management of Neonatal Liver Tumors

Current and Future Management Strategies for Relapsed or Progressive Hepatoblastoma

Decision making by parents of children with incurable cancer who opt for enrollment on a phase I trial compared with choosing a do not resuscitate/terminal care option

Differential diagnosis and work-up of elevations of alkaline phosphatase following therapy for pediatric cancer

Disease control intervals in high-risk neuroblastoma

Dose escalation of intravenous irinotecan using oral cefpodoxime: A phase I study in pediatric patients with refractory solid tumors ⬇️

Epidemiology and management options for colorectal cancer in children

Epidermal growth factor receptor polymorphisms and risk for toxicity in paediatric patients treated with gefitinib

Evaluation of gefitinib for treatment of refractory solid tumors and central nervous system malignancies in pediatric patients

Factors that distinguish symptoms of most concern to parents from other symptoms of dying children

Familial adenomatous polyposis in two brothers with hepatoblastoma: implications for diagnosis and screening

Feasibility of Pegylated Interferon in Children and Young Adults With Resected High-Risk Melanoma.

Imaging analysis of hepatoblastoma resectability across neoadjuvant chemotherapy.

Management of Colorectal Carcinoma in Children and Young Adults ⬇️

Multimodality Treatment of Pediatric Esthesioneuroblastoma.

Parent-clinician communication intervention during end-of-life decision making for children with incurable cancer.

Phase 1 study of an oxaliplatin and etoposide regimen in pediatric patients with recurrent solid tumors

Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors: a children's oncology group study

Phase I and clinical pharmacology study of bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory/recurrent solid tumors.

Phase I and pharmacokinetic study of topotecan administered orally once daily for 5 days for 2 consecutive weeks to pediatric patients with refractory solid tumors

Phase I clinical trial of ifosfamide, oxaliplatin, and etoposide (IOE) in pediatric patients with refractory solid tumors

Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma

Pilot study to evaluate MYCN expression as a neuroblastoma cell marker to detect minimal residual disease by RT-PCR.

Radiation therapy as part of local control of metastatic neuroblastoma: the St Jude Children's Research Hospital experience.

Rapamycin increases neuroblastoma xenograft and host stromal derived osteoprotegerin inhibiting osteolytic bone disease in a bone metastasis model ⬇️

Rare Tumors in Children: Progress Through Collaboration

Reducing irinotecan-associated diarrhea in children

Safety of ultrasound contrast agents in the pediatric oncologic population: a single-institution experience

Serum ALT elevations in survivors of childhood cancer. A report from the St. Jude Lifetime Cohort Study

Subsequent malignant neoplasms in pediatric patients initially diagnosed with neuroblastoma

The role of chest computed tomography (CT) as a surveillance tool in children with high-risk neuroblastoma.

Treatment outcomes in black and white children with cancer: results from the SEER database and St Jude Children's Research Hospital, 1992 through 2007

Typhlitis in childhood cancer

Tyrosine kinase inhibitor enhances the bioavailability of oral irinotecan in pediatric patients with refractory solid tumors

Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee.